Clarity with
Crown

Recognize your next clinical candidate when you see it.

Our Translational Platforms enable our clients to identify the right patients for the right treatment. Having models which more accurately mimic human disease and population dynamics are key to successfully translating promising compounds into successful clinical candidates, whether treating Oncology or Diabetes related diseases.

Magnify your
insights

Understand the mechanisms of disease.

Our scientific acumen and experience will give you a deeper understanding of not just the pharmacological profile of your compound, but more importantly, a clear understanding of which compounds to progress into the clinic. Take a look at our publications to get a deeper understanding of the depth of our scientific expertise.

Begin with the
end insight

Connecting science to patients.

We help our clients solve some of today's most pressing problems in oncology, cardiovascular, and metabolic disease by answering some of the most challenging questions about human biology.

CrownBio GIVES BACK

CVMD

Models of Obesity

obesity-img.jpg

CrownBio’s preclinical Translational Technology Platforms provide spontaneous & diet-induced obesity (DIO) models, to support the transition of new agents into the clinic.

Learn More

Oncology

Oncology Databases

databases-img.jpg

Our unique databases provide a curated source of well-characterized models available to use for drug discovery including PDX models, cell lines, and syngeneic models.

Learn More

CVMD

Diabetes Models

oncoexpress-img.jpg

Models of both Type 1 and Type 2 diabetes, including conventional, as well as unique, highly translatable models for in vivo efficacy studies of antidiabetic agents.

Learn More

Latest from our Blog

September 27, 2016

All You Need to Know About Non-Alcoholic Fatty Liver Disease

Non-Alcoholic Fatty liver disease (NAFLD) is a complex condition where an excessive amount of fat accumulates in the liver, independently from alcohol consumption. It is currently unclear how and why NAFLD develops, although obesity is a clear risk factor. Improved preclinical models are currently needed so that we can gain a better...

Read More

September 27, 2016

All You Need to Know About Non-Alcoholic Fatty Liver Disease

Non-Alcoholic Fatty liver disease (NAFLD) is a complex condition where an excessive amount of...

Read More

September 13, 2016

Obesity Linked To Self-Eating Beige Fat

Humans, like all mammals, have two types of fat with completely opposite functions: white, which...

Read More

September 6, 2016

All About Leukemia for Childhood Cancer Month

September is Childhood Cancer Awareness Month, raising awareness and providing time for...

Read More

August 23, 2016

Put Your Glasses On, Tumor Pharmacology Goes 3D

Attrition rates in oncology drug development are higher than in other disease areas, with almost...

Read More

August 2, 2016

Study Finds Perfect Therapeutic Match To Fight a Common Form of Leukemia

Acute lymphoblastic leukemia (ALL) is the most common type of childhood cancer, characterized by...

Read More

Upcoming Events


Sep 25-29, 2016

Immuno-Oncology AACR Special Conference. Second CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival

New York, NY

Learn More


Sep 28, 2016

CrownBio Inaugural Taiwan Symposium on Precision Medicine for Cancer

Taipei City, Taiwan

Learn More


Oct 6-8, 2016

The 75th Annual Meeting of the Japanese Cancer Association

Yokohama, Japan

Learn More


Oct 7-11, 2016

ESMO 2016 Congress: From Disease Treatment to Patient Care

Copenhagen, Denmark

Learn More


Oct 13-15, 2016

2016 International Conference on Diabetes and Metabolism

Seoul, Korea

Learn More


Oct 20-23, 2016

Tumor Immunology and Immunotherapy

Boston, MA

Learn More


Nov 2-5, 2016

AACR New Horizons in Cancer Research: Delivering Cures Through Cancer Science

Shanghai, China

Learn More


November 6-9, 2016

SITC 2016

Maryland, MD

Learn More


Nov 15-20, 2016

ASN Kidney Week 2016

Chicago, IL

Learn More


November 16-18, 2016

2nd Annual ICI Immune Checkpoint Inhibitors Europe 2016

Munich, Germany

Learn More


Nov 28, 2016

CrownBio Oncology Symposium: Translational Oncology and the Impact of Immuno-Oncology

Munich, Germany

Learn More


Nov 28, 2016

EORTC-NCI-AACR Molecular Targets and Cancer Therapeutics Symposium

Munich, Germany

Learn More


Dec 3-6, 2016

58th ASH Annual Meeting & Exposition

San Diego, CA

Learn More


Dec 6-8, 2016

Tumor Models London 2016

London, UK

Learn More